Citius Oncology, Inc. (CTOR) stock
CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.52−0.03 (-5.87%)
Close on Nov 12, 2026Market cap $48.56MP/E –Yield –
Citius Oncology total assets
Total assets on the balance sheet at the end of each period.
Citius Oncology's total assets was $112.09M at Jun 30, 2026. For fiscal 2025 it was $100.94M, up 48.0% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $100.94M | +48.0% |
| FY2022 | Dec 31, 2022 | $68.19M | +53838.7% |
| FY2021 | Dec 31, 2021 | $126.42K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $112.09M | +22.2% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $100.70M | +10.1% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $109.97M | +21.5% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $100.94M | +48.0% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $91.71M | +35619.9% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $91.44M | +72228.7% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $90.48M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $68.19M | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $256.75K | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $126.42K | – |
See a number that looks wrong?